These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17293180)

  • 21. Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions: experience at a single center.
    Kirma C; Izgi A; Dundar C; Tanalp AC; Oduncu V; Aung SM; Sonmez K; Mutlu B; Ozdemir N; Erentug V
    Circ J; 2008 May; 72(5):716-21. PubMed ID: 18441449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging.
    Eitel I; Nowak M; Stehl C; Adams V; Fuernau G; Hildebrand L; Desch S; Schuler G; Thiele H
    Am Heart J; 2010 May; 159(5):882-90. PubMed ID: 20435200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-hospital clinical outcome in elderly patients with acute myocardial infarction treated with primary angioplasty.
    Tespili M; Guagliumi G; Valsecchi O; Musumeci G; Vassileva A; Saino A; Scuri PM; Gavazzi A
    Ital Heart J; 2003 Mar; 4(3):193-8. PubMed ID: 12784746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation of serum uric acid levels with coronary flow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention].
    Wang JW; Chen YD; Wang CH; Zhu XL
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(44):3100-3. PubMed ID: 23328417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
    Patel MR; Worthley SG; Stebbins A; Dill T; Rademakers FE; Valeti US; Barsness GW; Van de Werf F; Hamm CW; Armstrong PW; Granger CB; Kim RJ
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of lymphocyte-to-monocyte ratio with the no-reflow phenomenon in patients who underwent a primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kurtul A; Yarlioglues M; Celik IE; Duran M; Elcik D; Kilic A; Oksuz F; Murat SN
    Coron Artery Dis; 2015 Dec; 26(8):706-12. PubMed ID: 26340546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of renal insufficiency on patients' outcomes in emergent angioplasty for acute myocardial infarction.
    Assali AR; Brosh D; Ben-Dor I; Solodky A; Fuchs S; Teplitsky I; Kornowski R
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):395-400. PubMed ID: 17195964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes after primary coronary intervention with drug-eluting stent implantation in diabetic patients with acute ST elevation myocardial infarction.
    Zhang Q; Shen J; Zhang RY; Qiu JP; Lu JD; Zhang Y; Chen YH; Zhang JF; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Chin Med J (Engl); 2007 Nov; 120(21):1862-7. PubMed ID: 18067756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of stent overexpansion to the angiographic no-reflow phenomenon in intravascular ultrasound-guided stent implantation for acute myocardial infarction.
    Maekawa Y; Asakura Y; Anzai T; Ishikawa S; Okabe T; Yoshikawa T; Ogawa S
    Heart Vessels; 2005 Feb; 20(1):13-8. PubMed ID: 15700197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diver CE versus Guardwire Plus for thrombectomy in patients with inferior myocardial infarction: a trial of aspiration of thrombus during primary angioplasty for inferior myocardial infarction.
    Yan HB; Wang J; Li N; Zhu XL; Gao H; Ai H; Li X; Ye M; Chi YP; Zhang H
    Chin Med J (Engl); 2007 Apr; 120(7):557-61. PubMed ID: 17442202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of circadian variation on outcomes in emergency acute anterior myocardial infarction percutaneous coronary intervention.
    Assali AR; Brosh D; Vaknin-Assa H; Fuchs S; Teplitsky I; Sela O; Kornowski R
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):221-6. PubMed ID: 16404750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial.
    Caixeta A; Lansky AJ; Mehran R; Brener SJ; Claessen B; Généreux P; Palmerini T; Witzenbichler B; Guagliumi G; Brodie BR; Dudek D; Fahy M; Dangas GD; Stone GW;
    EuroIntervention; 2013 Jun; 9(2):220-7. PubMed ID: 23518872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
    Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors and short-term prognosis of angiographically detected distal embolization after emergency percutaneous coronary intervention for ST-elevation acute myocardial infarction.
    Dong-bao L; Qi H; Zhi L; Shan W; Wei-ying J
    Clin Res Cardiol; 2009 Dec; 98(12):773-9. PubMed ID: 19730924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of preprocedural N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during stent implantation in patients with ST-segment elevation acute myocardial infarction.
    Hong SN; Ahn Y; Hwang SH; Yoon NS; Lee SR; Moon JY; Kim KH; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2007 Aug; 100(4):631-4. PubMed ID: 17697819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of slow/no-reflow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for acute myocardial infarction.
    Wang HJ; Lo PH; Lin JJ; Lee H; Hung JS
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):171-6. PubMed ID: 15390241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. X-sizer for thrombectomy in acute myocardial infarction improves ST-segment resolution: results of the X-sizer in AMI for negligible embolization and optimal ST resolution (X AMINE ST) trial.
    Lefèvre T; Garcia E; Reimers B; Lang I; di Mario C; Colombo A; Neumann FJ; Chavarri MV; Brunel P; Grube E; Thomas M; Glatt B; Ludwig J;
    J Am Coll Cardiol; 2005 Jul; 46(2):246-52. PubMed ID: 16022950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of the SYNTAX score to predict "no reflow" in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Magro M; Nauta ST; Simsek C; Boersma E; van der Heide E; Regar E; van Domburg RT; Zijlstra F; Serruys PW; van Geuns RJ
    Am J Cardiol; 2012 Mar; 109(5):601-6. PubMed ID: 22177003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
    Jeong YH; Kim WJ; Park DW; Choi BR; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
    Int J Cardiol; 2010 May; 141(2):175-81. PubMed ID: 19144424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient no reflow following primary percutaneous coronary intervention.
    Jinnouchi H; Sakakura K; Wada H; Arao K; Kubo N; Sugawara Y; Funayama H; Momomura S; Ako J
    Heart Vessels; 2014 Jul; 29(4):429-36. PubMed ID: 23807612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.